Evidence map›Paper›PMID 35164019›Full record

ArticleMolecules (Basel, Switzerland)2022

Investigation of the Anticancer Effect of

Mohamed A Nassan, Adil Aldhahrani, Hamada H Amer, Ahmed Elhenawy, Ayman A Swelum, Omar M Ali, Yasser H Zaki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Mohamed A NassanDepartment of Clinical Laboratory Sciences, Turabah University College, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0002-2806-9136
Adil AldhahraniDepartment of Clinical Laboratory Sciences, Turabah University College, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Hamada H AmerDepartment of Chemistry, Turabah University College, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Ahmed ElhenawyDepartment of Chemistry, Faculty of Science, Al-Azhar University, Cairo 11884, Egypt.
Ayman A SwelumDepartment of Theriogenology, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0003-3247-5898
Omar M AliDepartment of Chemistry, Turabah University College, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.ORCID 0000-0002-2653-1542
Yasser H ZakiDepartment of Chemistry, Faculty of Science, Beni-Suef University, Beni Suef 62514, Egypt.ORCID 0000-0002-3502-0445
Taif University · SAAl-Azhar University · EGBeni-Suef University · EGZagazig University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a major cause of death in women worldwide. In this study, 60 female rats were classified into 6 groups; negative control,

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAnimalsAntineoplastic AgentsCaco-2 CellsComputer SimulationDrug Evaluation, PreclinicalFemaleFishesHumansMammary Neoplasms, ExperimentalModels, MolecularMolecular Docking SimulationMolecular Targeted TherapyOrganophosphonatesPlant ExtractsQuinolines9,10-Dimethyl-1,2-benzanthraceneAntineoplastic AgentsOrganophosphonatesPlant ExtractsQuinolinesThymidylate Synthase3-acetyl-1-aminoquinolin-2(1H)-onebreast cancerDMBAthymidylate synthaseα-aminophosphonates

Identifiers

PMID35164019
PMCPMC8839308
OpenAlexW4210450475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.